Sign up
Quantellect · Congress · Trade Detail
NASDAQ: BATRKAtlanta Braves Holdings, Inc. Series C Common Stock
DemocratSenate

John W. Hickenlooper sold Atlanta Braves Holdings, Inc. Series C Common Stock (NASDAQ: BATRK)

John W. Hickenlooper (D-CO), a U.S. Senator, has disclosed 10 trades in Atlanta Braves Holdings, Inc. Series C Common Stock (BATRK) since 2022, 4 purchases and 6 sales, worth an estimated $989K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: John W. Hickenlooper sold $15,001 - $50,000 of Atlanta Braves Holdings, Inc. Series C Common Stock (NASDAQ: BATRK) on March 14, 2022. Since that trade, BATRK is up +100.95% against the S&P 500 up +88.55%, an outperformance of +12.40%.

Across these filings, John W. Hickenlooper has been a net seller of BATRK (a buy-to-sell ratio of 0.67). The most recent disclosed BATRK transaction shown was dated August 30, 2024. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

BATRK trades
10
Disclosed Vol
$989K
Buys
4
40%
Sells
6
60%
Buy / Sell
0.67
ratio
First → Last
2022–2024

John W. Hickenlooper's BATRK trades vs the price

BATRK is up +100.95% since John W. Hickenlooper sold on March 14, 2022, versus +88.55% for the S&P 500.

Performance since this trade

Price change since trade
+100.95%
S&P 500 change since trade
+88.55%
Outperformance vs S&P 500
+12.40%

All John W. Hickenlooper BATRK trades

TradedTypeSizeReturnEst. profit
August 30, 2024SELL$42.88+18.47%
August 28, 2024SELL$43.97+15.53%
August 28, 2024BUY$43.97+15.53%+$29K
March 20, 2023SELL$32.51+56.26%
November 23, 2022BUY$33.00+53.94%+$41K
November 23, 2022SELL$33.00+53.94%
November 21, 2022BUY$32.99+53.99%+$4K
November 21, 2022SELL$32.99+53.99%
March 14, 2022SELL$25.28+100.95%
March 14, 2022BUY$25.28+100.95%+$8K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

John W. Hickenlooper & BATRK trading FAQ

Is it legal for John W. Hickenlooper to trade Atlanta Braves Holdings, Inc. Series C Common Stock (BATRK) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Atlanta Braves Holdings, Inc. Series C Common Stock (BATRK), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did John W. Hickenlooper sell BATRK?

John W. Hickenlooper disclosed a sale of $15,001 - $50,000 of Atlanta Braves Holdings, Inc. Series C Common Stock (BATRK) on March 14, 2022, according to public STOCK Act filings.

How has BATRK performed since John W. Hickenlooper's trade?

Since John W. Hickenlooper sold BATRK on March 14, 2022, the stock is up +100.95%, versus +88.55% for the S&P 500 over the same period, an outperformance of +12.40%.

How many times has John W. Hickenlooper traded BATRK?

John W. Hickenlooper has disclosed 10 BATRK trades since 2022 (4 purchases and 6 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional BATRK trades?

Quantellect tracks every disclosed congressional trade in Atlanta Braves Holdings, Inc. Series C Common Stock (BATRK) on the Atlanta Braves Holdings, Inc. Series C Common Stock congressional trading page, which aggregates filings across all members of Congress.

John W. Hickenlooper's BATRK tradesAll congressional filings for Atlanta Braves Holdings, Inc. Series C Common StockJohn W. Hickenlooper's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.